FHTX
Price
$4.84
Change
-$0.02 (-0.41%)
Updated
Jun 27 closing price
Capitalization
268.12M
44 days until earnings call
HLOSF
Price
$3.17
Change
+$0.92 (+40.89%)
Updated
May 30 closing price
Capitalization
316.87M
Interact to see
Advertisement

FHTX vs HLOSF

Header iconFHTX vs HLOSF Comparison
Open Charts FHTX vs HLOSFBanner chart's image
Foghorn Therapeutics
Price$4.84
Change-$0.02 (-0.41%)
Volume$870.13K
Capitalization268.12M
HEALIOS K K
Price$3.17
Change+$0.92 (+40.89%)
Volume$100
Capitalization316.87M
FHTX vs HLOSF Comparison Chart in %
Loading...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FHTX vs. HLOSF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHTX is a Buy and HLOSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (FHTX: $4.84 vs. HLOSF: $3.17)
Brand notoriety: FHTX and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FHTX: 652% vs. HLOSF: 48%
Market capitalization -- FHTX: $269.79M vs. HLOSF: $316.87M
FHTX [@Biotechnology] is valued at $269.79M. HLOSF’s [@Biotechnology] market capitalization is $316.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FHTX’s FA Score shows that 0 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • FHTX’s FA Score: 0 green, 5 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, both FHTX and HLOSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FHTX’s TA Score shows that 4 TA indicator(s) are bullish while HLOSF’s TA Score has 2 bullish TA indicator(s).

  • FHTX’s TA Score: 4 bullish, 3 bearish.
  • HLOSF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than FHTX.

Price Growth

FHTX (@Biotechnology) experienced а +2.54% price change this week, while HLOSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

FHTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($317M) has a higher market cap than FHTX($268M). HLOSF YTD gains are higher at: 134.815 vs. FHTX (2.542).
FHTXHLOSFFHTX / HLOSF
Capitalization268M317M85%
EBITDA-91.89MN/A-
Gain YTD2.542134.8152%
P/E RatioN/AN/A-
Revenue23.5MN/A-
Total Cash221MN/A-
Total Debt34.9MN/A-
TECHNICAL ANALYSIS
Technical Analysis
FHTXHLOSF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
56%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
9%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYMBF59.46N/A
N/A
Cymbria Corp
LKSGF0.01N/A
N/A
Luks Group Vietnam Holdings Co., Ltd.
TUIFF8.22N/A
N/A
TUI AG
VDOMF0.05N/A
N/A
Val D Or Mng Corp.
AHICF16.17N/A
N/A
Asahi Intec Co., Ltd.

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-0.41%
ABOS - FHTX
54%
Loosely correlated
-7.44%
IPSC - FHTX
49%
Loosely correlated
-5.74%
IMNM - FHTX
48%
Loosely correlated
-0.23%
CRSP - FHTX
48%
Loosely correlated
N/A
NAUT - FHTX
47%
Loosely correlated
-12.57%
More

HLOSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-4.73%
PCVX - HLOSF
39%
Loosely correlated
-0.91%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
-0.41%
DMAC - HLOSF
22%
Poorly correlated
+0.79%
More